Hemab Therapeutics Holdings, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -75 | |||
EBITDA | -26,004 | -23,539 | -15,980 | -16,485 |
EBIT | -26,079 | -23,612 | -16,057 | -16,560 |
Net Income | -24,150 | -22,687 | -12,209 | -15,306 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -22,525 | -21,696 | -15,333 | -13,049 |
Cash | 237,366 | 49,860 | ||
Basic Shares | 30,111 | 44,192 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -69,815 | -50,135 |
EBIT | -70,119 | -50,383 |
Net Income | -63,913 | -48,707 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -61,491 | -45,874 |
Cash | 87,974 | 74,407 |
Basic Shares | 27,442 | 44,192 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.80 |
2026-03-31 | -$0.48 |